Suppr超能文献

苯妥英钠与苯唑西林在正常血清和尿毒症血清中的相互作用。

Phenytoin-oxacillin interactions in normal and uremic sera.

作者信息

Dasgupta A, Sperelakis A, Mason A, Dean R

机构信息

Department of Pathology, University of New Mexico, School of Medicine, Albuquerque, USA.

出版信息

Pharmacotherapy. 1997 Mar-Apr;17(2):375-8.

PMID:9085332
Abstract

Displacement of phenytoin (90% bound to albumin) by other strongly albumin-bound drugs such as salicylate and valproic acid may result in an increase in pharmacologically active free concentrations. The antibiotic oxacillin is also strongly bound to albumin and is often administered to patients receiving phenytoin. Oxacillin at a concentration of 15 micrograms/ml caused no significant displacement of phenytoin in a serum pool prepared from patients receiving phenytoin. However, a significant increase in the free phenytoin concentration was seen at an oxacillin concentration of 50 micrograms/ml. We also prepared a serum pool from uremic patients and another from patients with hypoalbuminemia and supplemented both of them with phenytoin. Significant increases in the free phenytoin concentration occurred with both 15- and 50-microgram/ml concentrations of oxacillin. In one hypoalbuminemic patient receiving both phenytoin and intravenous high-dose oxacillin, the free phenytoin fraction was 22.5% before oxacillin therapy, 24.1% 12 hours after first dose of oxacillin, and 27.2% after 60 hours, indicating the possibility of in vivo displacement of phenytoin by oxacillin. We conclude that the phenytoin-oxacillin interaction is not significant at lower dosages of oxacillin usually prescribed for oral therapy. However, the interaction may be significant at high concentrations of oxacillin, especially in patients with hypoalbuminemia or uremia.

摘要

苯妥英(90%与白蛋白结合)会被其他与白蛋白结合力强的药物(如水杨酸盐和丙戊酸)置换,这可能导致具有药理活性的游离浓度增加。抗生素苯唑西林也与白蛋白紧密结合,常用于接受苯妥英治疗的患者。在从接受苯妥英治疗的患者中制备的血清库中,浓度为15微克/毫升的苯唑西林未引起苯妥英的显著置换。然而,当苯唑西林浓度为50微克/毫升时,游离苯妥英浓度显著增加。我们还从尿毒症患者和低白蛋白血症患者中分别制备了血清库,并在其中补充了苯妥英。当苯唑西林浓度为15微克/毫升和50微克/毫升时,游离苯妥英浓度均显著增加。在一名同时接受苯妥英和静脉注射高剂量苯唑西林的低白蛋白血症患者中,苯唑西林治疗前游离苯妥英分数为22.5%,首次注射苯唑西林12小时后为24.1%,60小时后为27.2%,这表明苯唑西林在体内可能会置换苯妥英。我们得出结论,通常用于口服治疗的较低剂量苯唑西林时,苯妥英 - 苯唑西林相互作用不显著。然而,在高浓度苯唑西林时,尤其是在低白蛋白血症或尿毒症患者中,这种相互作用可能很显著。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验